HYPERTENSION MANAGEMENT IN METABOLIC SYNDROME

Hypertension is one of the key risk factors for cardiovascular morbidity and mortality. Metabolic syndrome (synonyms: syndrome X, insulin resistance syndrome) is characterized by increased visceral fat mass, decreased sensitivity of peripheral tissues to insulin (insulin resistance) and hyperinsulinemia, which cause disorders of carbohydrate, lipid, and purine metabolism. Hypertension is an integral component of the metabolic syndrome. The severity of hypertension in patients with metabolic syndrome is higher in comparison with patients without metabolic disorders. In patients with metabolic syndrome, the probability of cardiac and brain damage increases fivefold, kidney damage threefold, and the vessels twofold. The presence of diabetes reduces the likelihood of achieving effective control of blood pressure by 1.4 times, hypercholesterolemia — by 1.5 times, obesity — by 1.7 times. In the presence of any three factors, the effectiveness of treatment is reduced twofold. In this article, approaches to the management of patients with hypertension and metabolic syndrome, aspects of non-drug therapy, target blood pressure levels, and the choice of drugs are presented in accordance with evidence-based medicine and current recommendations.

1. Recommendations for the management of patients with metabolic syndrome: clinical guidelines. Ministry of Health of the Russian Federation. 2013; 42 р. [Electronic resource]. URL: http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwjuybvrh9DfAhURp4sKHcYnDJoQFjAAegQIChAC&url=http%3A%2F%2Fwww.gipertonik.ru%2Ffiles%2Frecommendation%2FRecommendations_metabolic_syndrome.doc&usg=AOvVaw0OlaDnVqEqE_s6p37JaUFm (date of the application: 03.01.2019) [In Russian]

2. Yezhov M.V., Sergienko I.V., Aronov D.M. et al. Diagnosis and correction of lipid metabolic disorders for the prevention and treatment of atherosclerosis. Russian recommendations. VI revision. Atherosclerosis and Dyslipidemia. 2017; 3: 5-22. [In Russian]

3. Oganov R.G., Denisov I.N. Comorbid Pathology in Clinical Practice. Clinical guidelines. Cardiovascular Therapy and Prevention. 2017; 16(6): 5-56. [In Russian] https://doi.org/10.15829/1728-88002017-6-5-56

4. Reznik E.V., Nikitin I.G. New ACC/AHA and ESC/ESH recommendations on arterial hypertension. Cardiovascular therapy and prevention. 2018; 17(5): 99-119 [In Russian]

5. Rotar O.A. Prevalence of cardiometabolic disorders, target organ damage and mechanisms of their progression in office workers. dis. ... Dr. med Sciences, St. Petersburg. 2016; 250 р. [in Russian].

6. Chazova, I.E., Nedogod, S.V., Zhernakova, Yu.V. et al., Recommendations for the management of patients with arterial hypertension with metabolic disorders. // Kardiologicheskij Vestnik. 2014; 9(1): 3-57. [in Russian].

7. Chazova I.E., Oshchepkova E.V., Zhernakova Yu.V., Clinical recommendations. Hypertension in adults. 016; 70 р. [Electronic resource]. URL: http://webmed.irkutsk.ru/doc/pdf/fedhypert.pdf. (date of the application: 03.01.2019) [In Russian]

8. Bakris G., Sorrentino M., Redefining Hypertension — Assessing the New Blood-Pressure Guidelines. N Engl J Med. 2018; 378 (6): 497-499.

9. . Catapano A.L., Graham I., De Backer G. et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016; 37 (39): 2999-3058.

10. Cuspidi C., Tadic M., Grass, G. et al. Treatment of hypertension: The ESH/ESC guidelines recommendations. Pharmacol Res. 2018; 128: 315-321.

11. Group S.R., Wright J.T., Jr., Williamson J.D. et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015; 373 (22): 2103-16.

12. Mancia G., Fagard R., Narkiewicz K. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Journal of Hypertension 2013; 31(7):1281-1357

13. Muntner P., Carey R.M., Gidding S. et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018; 137 (2): 109-118.

14. Whelton P.K., Carey R.M., Aronow W.S. et al. 2017 ACC/AHA/ AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Associat ion Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71 (6): e13-e115.

15. Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39 (33): 3021-3104.